Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors

Abstract The combination of hypomethylating agents (HMA) and venetoclax (VEN) has transformed acute myeloid leukemia (AML) treatment. Data on donor lymphocyte infusion (DLI) with HMA/VEN for relapse after allogeneic hematopoietic cell transplantation (alloHCT) remain limited. We retrospectively anal...

Descripció completa

Dades bibliogràfiques

Autors principals:	Miriam Mozaffari Jovein, Thomas Meyer, Miguel Waterhouse, Dietmar Pfeifer, Jesús Duque-Afonso, Michael Lübbert, Kristina Maas-Bauer, Ralph Wäsch, Hartmut Bertz, Justus Duyster, Robert Zeiser, Jürgen Finke, Claudia Wehr
Format:	Artigo
Idioma:	Inglês
Publicat:	Springer 2026-03-01
Col·lecció:	Annals of Hematology
Matèries:	Allogeneic stem cell transplantation Relapsed AML Myeloid neoplasms Hypomethylating agents Donor lymphocyte infusions Venetoclax
Accés en línia:	https://doi.org/10.1007/s00277-026-06973-7
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!